U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

2022
358
Name Type Language
Tirzepatide
USAN   INN  
Official Name English
LY3298176
Code English
LY-3298176
Code English
TIRZEPATIDE [USAN]
Common Name English
L-Tyrosyl-2-methylalanyl-L-α-glutamylglycyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-α-aspartyl-L-tyrosyl-L-seryl-L-isoleucyl-2-methylalanyl-L-leucyl-L-α-aspartyl-L-lysyl-L-isoleucyl-L-alanyl-L-glutaminyl-N6-[(22S)-22,42-dicarboxy-1,10,19,24-tet
Systematic Name English
MOUNJARO
Brand Name English
L-Serinamide, L-tyrosyl-2-methylalanyl-L-α-glutamylglycyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-α-aspartyl-L-tyrosyl-L-seryl-L-isoleucyl-2-methylalanyl-L-leucyl-L-α-aspartyl-L-lysyl-L-isoleucyl-L-alanyl-L-glutaminyl-N6-[(22S)-22,42-dicarboxy-
Systematic Name English
TIRZEPATIDE [JAN]
Common Name English
Tirzepatide [WHO-DD]
Common Name English
tirzepatide [INN]
Common Name English
BG-121
Code English
ZEPBOUND
Brand Name English
Code System Code Type Description
USAN
EF-81
Created by admin on Sat Dec 16 13:24:27 GMT 2023 , Edited by admin on Sat Dec 16 13:24:27 GMT 2023
PRIMARY
FDA UNII
OYN3CCI6QE
Created by admin on Sat Dec 16 13:24:27 GMT 2023 , Edited by admin on Sat Dec 16 13:24:27 GMT 2023
PRIMARY
DAILYMED
OYN3CCI6QE
Created by admin on Sat Dec 16 13:24:27 GMT 2023 , Edited by admin on Sat Dec 16 13:24:27 GMT 2023
PRIMARY
INN
10849
Created by admin on Sat Dec 16 13:24:27 GMT 2023 , Edited by admin on Sat Dec 16 13:24:27 GMT 2023
PRIMARY
WIKIPEDIA
Tirzepatide
Created by admin on Sat Dec 16 13:24:27 GMT 2023 , Edited by admin on Sat Dec 16 13:24:27 GMT 2023
PRIMARY
CAS
2023788-19-2
Created by admin on Sat Dec 16 13:24:27 GMT 2023 , Edited by admin on Sat Dec 16 13:24:27 GMT 2023
PRIMARY
NCI_THESAURUS
C174817
Created by admin on Sat Dec 16 13:24:27 GMT 2023 , Edited by admin on Sat Dec 16 13:24:27 GMT 2023
PRIMARY
DRUG BANK
DB15171
Created by admin on Sat Dec 16 13:24:27 GMT 2023 , Edited by admin on Sat Dec 16 13:24:27 GMT 2023
PRIMARY
RXCUI
2601723
Created by admin on Sat Dec 16 13:24:27 GMT 2023 , Edited by admin on Sat Dec 16 13:24:27 GMT 2023
PRIMARY
ACTIVE MOIETY
Tirzepatide
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966